Australia-China relations sour, US markets soar, ASX futures up 15 points

Published 27-AUG-2020 10:18 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

The S&P/ASX 200 index (XJO) slumped 0.7% or 45 points on Wednesday to close at 6116 points as a poor round of profit results took its toll on a number of sectors.

The four big banks were caught in the sell-offs and Telstra was also hard hit, placing a drag on the broader communications index.

The large miners also came under pressure as their share prices were sold down in response to a retracement in the iron ore price.

Futures markets point to a turnaround today, largely reflecting strength in overseas markets as both the NASDAQ and the S&P 500 continued to set record highs.

Leading the way was Netflix with a gain of more than 10%, but there were also strong performances from the likes of Microsoft Corporation and Tesla.

The ASX SPI200 is up 15 points to 6095 points, perhaps a little suppressed due to increased Australia-China political ructions stemming from a review announced yesterday by the Morrison government.

24 hours

There was little movement in markets in Japan and Hong Kong with the Nikkei 225 closing down six points at 23,290 points and the Hang Seng gaining six points to close at 25,491 points.

However, the Shanghai Composite fell sharply, closing down 1.3% at 3330 points.

There were across-the-board gains in European markets with the DAX leading the way as it gained 128 points or 1% to close at 13,190 points and the CAC 40 adding 40 points or 0.8%, closing at 5048 points.

There was only a nominal movement in the FTSE 100 as it gained less than 10 points to close at 6045 points.

Most of the action was in the US where the S&P 500 gained 1% to close at yet another record high of 3478 points.

The NASDAQ soared 1.7% or nearly 200 points to close at 11,665 points, up an incredible 70% from the coronavirus low that was struck in late March.

The Dow gained 0.3% or 83 points, closing at 28,332 points.

On the commodities front, gold was back in favour as it rallied 2% or US$40 per ounce to push above US$1962 per ounce.

The Brent Crude Oil Continuous Contract built on gains made earlier in the week, and it is currently hovering in the vicinity of US$46.30 per barrel, up from less than US$44 per barrel on Friday.

The big miners could recover some of yesterday’s lost ground with the iron ore price rebounding 1% to US$124.20 per tonne.

There was also strength in base metals with copper stringing together its third consecutive day of gains to hit the psychological US$3.00 per pound mark.

Nickel was the other strong performer as the metal continued its outstanding run which now reflects nine consecutive days of gains, looking increasingly likely to claim US$7.00 per pound.

Zinc and lead trailed off slightly, but the former has a particularly strong six-month chart which shows a gain of 35% since March.

The Australian dollar continued to strengthen, and it is currently fetching just over US$0.72.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X